Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Ranibizumab")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 265

  • Page / 11
Export

Selection :

  • and

Ranibizumab for the treatment of neovascular AMDKAISER, P. K; DO, D. V.International journal of clinical practice (Esher). 2007, Vol 61, Num 3, pp 501-509, issn 1368-5031, 9 p.Article

Ranibizumab for neovascular age-related macular degenerationROSENFELD, Philip J; BROWN, David M; HEIER, Jeffrey S et al.The New England journal of medicine. 2006, Vol 355, Num 14, pp 1419-1431, issn 0028-4793, 13 p.Article

Ranibizumab treatment of patients with ocular diseasesDUGEL, Pravin U.International ophthalmology clinics. 2006, Vol 46, Num 4, pp 131-140, issn 0020-8167, 10 p.Article

The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retinaLUKE, M; JANUSCHOWSKL, K; LÜKE, J et al.British journal of ophthalmology. 2009, Vol 93, Num 10, pp 1396-1400, issn 0007-1161, 5 p.Article

Retinal pigment epithelial tear after intravitreal ranibizumabBAKRI, Sophie J; KITZMANN, Anna S.American journal of ophthalmology. 2007, Vol 143, Num 3, pp 505-507, issn 0002-9394, 3 p.Article

Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degenerationBOYER, David S; ANTOSZYK, Andrew N; AWH, Carl C et al.Ophthalmology (Rochester, MN). 2007, Vol 114, Num 2, pp 246-252, issn 0161-6420, 7 p.Article

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration : Year 1 results of the FOCUS studyHEIER, Jeffrey S; BOYER, David S; CIULLA, Thomas A et al.Archives of ophthalmology (1960). 2006, Vol 124, Num 11, pp 1532-1542, issn 0003-9950, 11 p.Article

Ranibizumab (Lucentis) versus bevacizumab (Avastin) : modelling cost effectivenessRAFTERY, James; CLEGG, Andrew; JONES, Jeremy et al.British journal of ophthalmology. 2007, Vol 91, Num 9, pp 1244-1246, issn 0007-1161, 3 p.Article

A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edemaCHUN, Dal W; HEIER, Jeffrey S; TOPPING, Trexler M et al.Ophthalmology (Rochester, MN). 2006, Vol 113, Num 10, pp 1706-1712, issn 0161-6420, 7 p.Article

Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroidKIM, Ivana K; HUSAIN, Deeba; MILLER, Joan W et al.Investigative ophthalmology & visual science. 2006, Vol 47, Num 1, pp 357-363, issn 0146-0404, 7 p.Article

Ranibizumab versus verteporfin for neovascular age-related macular degenerationBROWN, David M; KAISER, Peter K; MICHELS, Mark et al.The New England journal of medicine. 2006, Vol 355, Num 14, pp 1432-1444, issn 0028-4793, 13 p.Article

Ranibizumab pour traiter la dégénérescence maculaire = Ranibizumab for macular degenerationThe Medical letter on drugs and therapeutics (Edition française). 2006, Vol 28, Num 24, pp 101-103, issn 0253-8512, 3 p.Article

Transcleral delivery of triamcinolone acetonide and ranibizumab to retinal tissues using macroesisSINGH, Rishi P; MATHEWS, Michael Ellen; KAUFMAN, Michael et al.British journal of ophthalmology. 2010, Vol 94, Num 2, pp 170-173, issn 0007-1161, 4 p.Article

Development of a novel homogenous electrochemiluminescence assay for quantitation of ranibizumab in human serumLOWE, John; MAIA, Mauricio; WAKSHULL, Eric et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 52, Num 5, pp 680-686, issn 0731-7085, 7 p.Article

Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degenerationROSENFELD, Philip J; HEIER, Jeffrey S; HANTSBARGER, Gary et al.Ophthalmology (Rochester, MN). 2006, Vol 113, Num 4, pp 623-632, issn 0161-6420, 10 p.Article

Innovations thérapeutiques dans la rétinopathie diabétique = New treatments for diabetic retinopathyMASSIN, P.Journal français d'ophtalmologie. 2011, Vol 34, Num 7, pp 491-497, issn 0181-5512, 7 p.Conference Paper

Traitement par injection intravitréenne de ranibizumab des néovaisseaux choroïdiens maculaires idiopathiques du sujet jeune = Intravitreal ranibizumab injection for the treatment of idiopathic choroidal neovascularisation in young patientsOUHADJ, O; DEGHEB, N; IDIR, S et al.Journal français d'ophtalmologie. 2012, Vol 35, Num 7, pp 514-522, issn 0181-5512, 9 p.Conference Paper

One-Year Results of Intravitreal Ranibizumab with or without Photodynamic Therapy for Polypoidal Choroidal VasculopathySONG, Min-Hye; RYU, Hyun-Wook; ROH, Young-Jung et al.Ophthalmologica (Basel). 2011, Vol 226, Num 3, pp 119-126, issn 0030-3755, 8 p.Article

I ntravitrea I bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathyCHO, H. J; KIM, J. W; LEE, D. W et al.Eye (London. 1987). 2012, Vol 26, Num 3, pp 426-433, issn 0950-222X, 8 p.Article

UTILISATION DES ANTICORPS ANTI-VEGF EN OPHTALMOLOGIE = VEGF INHIBITORS IN OPHTHALMOLOGYTHYS, J; DUPONT, G; RAKIC, J. M et al.RMLG. Revue médicale de Liège. 2009, Vol 64, Num 5-6, pp 323-326, issn 0370-629X, 4 p.Article

Bevacizumab versus ranibizumab dans la prise en charge de la dégénérescence maculaire liée à l'âge exsudative: étude rétrospective chez 58 patients = Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration: A retrospective study of 58 patientsDE BATS, F; GRANGE, J.-D; CORNUT, P.-L et al.Journal français d'ophtalmologie. 2012, Vol 35, Num 9, pp 661-666, issn 0181-5512, 6 p.Article

Anti-VEGF therapy for choroidal neovascu larisation previously treated with photodynamic therapyJYOTHI, S; CHOWDHURY, H. R; CHONG, V et al.Eye (London. 1987). 2010, Vol 24, Num 6, pp 1018-1023, issn 0950-222X, 6 p.Article

Néovaisseaux choroïdiens du myope fort: traitement par injection intravitréenne de ranibizumab = Intravitreal ranibizumab injections for the treatment of choroidal neovascularization complicating high myopiaOUHADJ, O; BOUARFA, A; AKEL, S et al.Journal français d'ophtalmologie. 2010, Vol 33, Num 9, pp 649-654, issn 0181-5512, 6 p.Article

Traitement des décollements de l'épithélium pigmentaire par photothérapie dynamique, IVT de ranibizumab, sous-ténonienne de triamcinolone = Triple therapy for the treatment of choroidal neovascularization with pigment epithelium detachment in age-related macular degenerationHAJOULI, N; HIESCH, A; QUINTYN, J.-C et al.Journal français d'ophtalmologie. 2010, Vol 33, Num 7, pp 487-492, issn 0181-5512, 6 p.Conference Paper

Traitement des néovaisseaux chordïdiens rétrofovéolaires naïfs du myope fort par injection intravitréenne de ranibizumab: résultats à 12 mois = Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month resultsCORNUT, P.-L; POLI, M; FELDMAN, A et al.Journal français d'ophtalmologie. 2010, Vol 33, Num 5, pp 327-333, issn 0181-5512, 7 p.Conference Paper

  • Page / 11